Biography :
He serves as an NIH Secondary Review, and Editorial Board Member for Toxicology (IF: 4.2) and Steroids (IF: 2.9). He is also a reviewer for China’s Changjiang Scholars Program and NSFC funds, Chair of the Reproductive Pharmacology Committee (Chinese Pharmacological Society), and holds leadership roles in multiple national academic committees. With 3 NIH grants, 5 NSFC projects, and 465 SCI papers (including 4 in PNAS and 10 with IF >10), he was named a Highly Cited Scientist (2021–2024).